Viewing Study NCT04697069


Ignite Creation Date: 2025-12-24 @ 10:49 PM
Ignite Modification Date: 2025-12-25 @ 8:19 PM
Study NCT ID: NCT04697069
Status: TERMINATED
Last Update Posted: 2025-09-22
First Post: 2020-12-23
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: A Study to Evaluate of the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Acneiform Rash
Sponsor: Vanda Pharmaceuticals
Organization: